NICOLE HIGGINS: Open Payments
NPI 1689986267 · GLOVERSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$828 in 33 payments from 15 companies in 2025. Trend: 2023 $492 · 2024 $764 · 2025 $828
Food & beverage: $828
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $302 |
| ABBVIE INC. | 5 | $108 |
| Novo Nordisk Inc | 4 | $85 |
| Lilly USA, LLC | 3 | $63 |
| PFIZER INC. | 2 | $52 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Dexcom, Inc. | 1 | $25 |
| Abbott Laboratories | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $21 |
Products named: AIRSUPRA, FARXIGA, ELIQUIS, QULIPTA, Rybelsus, MOUNJARO, VRAYLAR, Wegovy.
Industry payments across NY — which companies pay providers there.
